
Laboratory Corporation of America Holdings LH
€ 223.68
-0.67%
Quartalsbericht 2025-Q3
hinzugefügt 31.10.2025
Laboratory Corporation of America Holdings Anteile 2011-2025 | LH
Anteile Jährlich Laboratory Corporation of America Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83.9 M | 87.1 M | 91.1 M | 93.1 M | 97.3 M | 97.9 M | 101 M | 102 M | 102 M | 98.8 M | 84.8 M | 85.7 M | 93.5 M | 97.8 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 102 M | 83.9 M | 94.1 M |
Anteile Vierteljährlich Laboratory Corporation of America Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83.1 M | 83.4 M | 83.6 M | 83.4 M | 84 M | 84.1 M | 84.1 M | 83.9 M | 86.6 M | 88.7 M | 88.4 M | 88.2 M | 90.2 M | 92.3 M | 93.2 M | 93.1 M | 96.3 M | 97.4 M | 97.6 M | 97.5 M | 97.4 M | 97.3 M | 97.2 M | 97.2 M | 97.6 M | 98.1 M | 98.6 M | 98.9 M | 102 M | 102 M | 102 M | 102 M | 102 M | 102 M | 102 M | 103 M | 103 M | 102 M | 102 M | 101 M | 101 M | 101 M | 91.9 M | 84.6 M | 84.9 M | 84.7 M | 84.8 M | 85.7 M | 89.2 M | 92 M | 92.9 M | 93.5 M | 89.2 M | 92 M | 92.9 M | 97.8 M | 101 M | 101 M | 100 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 103 M | 83.1 M | 94 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Brainsway Ltd.
BWAY
|
31.2 M | $ 17.13 | 1.66 % | $ 99.4 M | ||
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
DarioHealth Corp.
DRIO
|
28.4 M | $ 12.15 | 2.14 % | $ 345 M | ||
|
DexCom
DXCM
|
386 M | $ 66.06 | -1.34 % | $ 25.5 B | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
185 M | $ 101.57 | 0.07 % | $ 18.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.0 | 1.59 % | $ 172 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
1.27 M | $ 1.56 | -3.7 % | $ 1.98 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
27.8 M | $ 38.95 | 0.82 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
731 M | $ 227.29 | 0.42 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 26.94 | -0.74 % | $ 815 M | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
21.2 M | $ 1 408.65 | 1.08 % | $ 29.9 B | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
127 M | $ 12.15 | 2.53 % | $ 1.54 B | ||
|
Neogen Corporation
NEOG
|
217 M | $ 6.84 | -0.36 % | $ 1.48 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
53.8 M | $ 19.9 | -3.21 % | $ 1.07 B | ||
|
Pacific Biosciences of California
PACB
|
254 M | $ 2.12 | - | $ 538 M | ||
|
Celcuity
CELC
|
39.4 M | $ 101.74 | -3.33 % | $ 4.01 B | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
31.9 K | $ 3.35 | -6.42 % | $ 107 K | ||
|
Koninklijke Philips N.V.
PHG
|
904 M | $ 26.46 | -0.62 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.3 | -13.39 % | $ 8.8 M | ||
|
Precipio
PRPO
|
1.3 M | $ 24.67 | -1.2 % | $ 32 M | ||
|
Quidel Corporation
QDEL
|
42.1 M | $ 28.82 | 0.07 % | $ 1.21 B | ||
|
IQVIA Holdings
IQV
|
181 M | $ 224.13 | 0.84 % | $ 40.6 B | ||
|
QIAGEN N.V.
QGEN
|
223 M | $ 45.14 | -0.21 % | $ 10 B | ||
|
Guardant Health
GH
|
123 M | $ 103.55 | 1.45 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | ||
|
Sotera Health Company
SHC
|
283 M | $ 16.76 | -0.42 % | $ 4.74 B | ||
|
Soleno Therapeutics
SLNO
|
40.2 M | $ 49.79 | -4.25 % | $ 2 B | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
382 M | $ 574.27 | 0.46 % | $ 219 B | ||
|
Illumina
ILMN
|
159 M | $ 134.66 | -0.16 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
51.4 M | $ 197.59 | 2.36 % | $ 10.2 B | ||
|
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.96 | -10.6 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
59.8 M | $ 31.39 | 1.47 % | $ 1.88 B | ||
|
Quotient Limited
QTNT
|
91.6 M | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 184.04 | 0.81 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
130 M | $ 7.63 | -2.8 % | $ 989 M | ||
|
Myriad Genetics
MYGN
|
90.6 M | $ 7.07 | -2.01 % | $ 641 M |